cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients

International Journal of Medical Microbiology

Volumn 296, Issue 6, 2006, Pages 421-434

  Xu, Zheng ^a   Zhang, Li Xin ^b   Zhang, Jun Dong ^a   Cao, Yong Bing ^a   Yu, Yuan Yuan ^a   Wang, De Jun ^a   Ying, Kang ^c   Chen, Wan Sheng ^a   Jiang, Yuan Ying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Bone marrow transplant; Candida albicans; Differential gene expression; Drug resistance; Microarray

Indexed keywords

ABC TRANSPORTER; ANTIFUNGAL AGENT; CARRIER PROTEIN; COMPLEMENTARY DNA; FLUCONAZOLE; MESSENGER RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BONE MARROW TRANSPLANTATION; CANDIDA ALBICANS; DNA MICROARRAY; FUNGAL GENE; FUNGAL VIRULENCE; FUNGUS ISOLATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE INTERACTION; GENE ISOLATION; GENETIC REGULATION; GENETIC VARIABILITY; HUMAN; LARGE SCALE PRODUCTION; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHENOTYPE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY;

EID: 33748466564     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2006.03.004     Document Type: Article

References (51)

1. Anderson J.B., Sirjusingh C., Parsons A.B., Boone C., Wickens C., Cowen L.E., and Kohn L.M. Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiae. Genetics 163 (2003) 1287-1298
2. Barker K.S., Crisp S., Wiederhold N., Lewis R.E., Bareither B., Eckstein J., Barbuch R., Bard M., and Rogers P.D. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J. Antimicrob. Chemother. 54 (2004) 376-385
3. Calvet H.M., Yeaman M.R., and Filler S.G. Reversible fluconazole resistance in Candida albicans: a potential in vitro model. Antimicrob. Agents Chemother. 41 (1997) 535-539
4. Cao Y.Y., Cao Y.B., Xu Z., Ying K., Li Y., Xie Y., Zhu Z.Y., Chen W.S., and Jiang Y.Y. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob. Agents Chemother. 49 (2005) 584-589
5. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
6. Coste A.T., Karababa M., Ischer F., Bille J., and Sanglard D. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot. Cell 3 (2004) 1639-1652
7. Cowen L.E., Nantel A., Whiteway M.S., Thomas D.Y., Tessier D.C., Kohn L.M., and Anderson J.B. Population genomics of drug resistance in Candida albicans. Proc. Natl. Acad. Sci. USA 99 (2002) 9284-9289
8. Crisp R.J., Pollington A., Galea C., Jaron S., Yamaguchi-Iwai Y., and Kaplan J. Inhibition of heme biosynthesis prevents transcription of iron uptake genes in yeast. J. Biol. Chem. 278 (2003) 45499-45506
9. de Deken X., and Raymond M. Constitutive activation of the PDR16 promoter in a Candida albicans azole-resistant clinical isolate overexpressing CDR1 and CDR2. Antimicrob. Agents Chemother. 48 (2004) 2700-2703
10. Demain A.L., and Zhang L. Natural products and drug discovery. In: Zhang L., and Demain A. (Eds). Natural Products: Drug Discovery and Therapeutics Medicines (2005), Humana Press, Totowa, NJ 3-32
11. de Micheli M., Bille J., Schueller C., and Sanglard D. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol. Microbiol. 43 (2002) 1197-1214
12. DeRisi J., van den Hazel B., Marc P., Balzi E., Brown P., Jacq C., and Goffeau A. Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett. 470 (2000) 156-160
13. Franz R., Kelly S.L., Lamb D.C., Kelly D.E., Ruhnke M., and Morschhäuser J. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42 (1998) 3065-3072
14. Hallstrom T.C., and Moye-Rowley W.S. Multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway in Saccharomyces cerevisiae. J. Biol. Chem. 275 (2000) 37347-37356
15. Hooshdaran M.Z., Barker K.S., Hilliard G.M., Kusch H., Morschhäuser J., and Rogers P.D. Proteomic analysis of azole resistance in Candida albicans clinical isolates. Antimicrob. Agents Chemother. 48 (2004) 2733-2735
16. Hwang C.S., Rhie G.E., Oh J.H., Huh W.K., Yim H.S., and Kang S.O. Copper- and zinc-containing superoxide dismutase (Cu/Zn SOD) is required for the protection of Candida albicans against oxidative stresses and the expression of its full virulence. Microbiology 148 (2002) 3705-3713
17. Jones T., Federspiel N.A., Chibana H., Dungan J., Kalman S., Magee B.B., Newport G., Thorstenson Y.R., Agabian N., Magee P.T., Davis R.W., and Scherer S. The diploid genome sequence of Candida albicans. Proc. Natl. Acad. Sci. USA 101 (2004) 7329-7334
18. Karababa M., Coste A.T., Rognon B., Bille J., and Sanglard D. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob. Agents Chemother. 48 (2004) 3064-3079
19. Kihara A., and Igarashi Y. Identification and characterization of a Saccharomyces cerevisiae gene, RSB1, involved in sphingoid long-chain base release. J. Biol. Chem. 277 (2002) 30048-30054
20. Kurita O., and Nishida Y. Involvement of mitochondrial aldehyde dehydrogenase ALD5 in maintenance of the mitochondrial electron transport chain in Saccharomyces cerevisiae. FEMS. Microbiol. Lett. 181 (1999) 281-287
21. Kusch H., Biswas K., Schwanfelder S., Engelmann S., Rogers P.D., Hecker M., and Morschhäuser J. A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains. Mol. Genet. Genomics 271 (2004) 554-565
22. Labbe S., Zhu Z., and Thiele D.J. Copper-specific transcriptional repression of yeast genes encoding critical components in the copper transport pathway. J. Biol. Chem. 272 (1997) 15951-15958
23. Li Y., Li Y., Tang R., Xu H., Qiu M., Chen Q., Chen J., Fu Z., Ying K., Xie Y., and Mao Y. Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays. J. Cancer Res. Clin. Oncol. 128 (2002) 369-379
24. Liu T.T., Lee R.E., Barker K.S., Lee R.E., Wei L., Homayouni R., and Rogers P.D. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob. Agents Chemother. 49 (2005) 2226-2236
25. Marr K.A., White T.C., vanBurik J.A.H., and Bowden R.A. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation. Clin. Infect. Dis. 25 (1997) 908-910
26. Marr K.A., Lyons C.N., Rustad T.R., Bowden R.A., and White T.C. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR. Antimicrob. Agents Chemother. 42 (1998) 2584-2589
27. Marr K.A., Lyons C.N., Ha K., Rustad T.R., and White T.C. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrob. Agents Chemother. 45 (2001) 52-59
28. Martchenko M., Alarco A.M., Harcus D., and Whiteway M. Superoxide dismutases in Candida albicans: transcriptional regulation and functional characterization of the hyphal-induced SOD5 gene. Mol. Biol. Cell 15 (2004) 456-467
29. Marvin M.E., Williams P.H., and Cashmore A.M. The Candida albicans CTR1 gene encodes a functional copper transporter. Microbiology 149 (2003) 1461-1474
30. Marvin M.E., Mason R.P., and Cashmore A.M. The CaCTR1 gene is required for high-affinity iron uptake and is transcriptionally controlled by a copper-sensing transactivator encoded by CaMAC1. Microbiology 150 (2004) 2197-2208
31. Morschhäuser J. The genetic basis of fluconazole resistance development in Candida albicans. Biochim. Biophys. Acta 1587 (2002) 240-248
32. Nawrocki A., Fey S.J., Goffeau A., Roepstorff P., and Larsen P.M. The effects of transcription regulating genes PDR1, pdr1-3 and PDR3 in pleiotropic drug resistance. Proteomics 1 (2001) 1022-1032
33. Nolte F.S., Parkinson T., Falconer D.J., Dix S., Williams J., Gilmore C., Geller R., and Wingard J.R. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob. Agents Chemother. 41 (1997) 196-199
34. Palmiter R.D. The elusive function of metallothioneins. Proc. Natl. Acad. Sci. USA 95 (1998) 8428-8430
35. Protchenko O., and Philpott C.C. Regulation of intracellular heme levels by HMX1, a homologue of heme oxygenase, in Saccharomyces cerevisiae. J. Biol. Chem. 278 (2003) 36582-36587
36. Quan H., Cao Y.Y., Xu Z., Zhao J.X., Gao P.H., Qin X.F., and Jiang Y.Y. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob. Agents Chemother. 50 (2006) 1096-1099
37. Ramanan N., and Wang Y. A high-affinity iron permease essential for Candida albicans virulence. Science 288 (2000) 1062-1064
38. Rees E.M., Lee J., and Thiele D.J. Mobilization of intracellular copper stores by the ctr2 vacuolar copper transporter. J. Biol. Chem. 279 (2004) 54221-54229
39. Rex J.H., Rinaldi M.G., and Pfaller M.A. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39 (1995) 1-8
40. Riggle P.J., and Kumamoto C.A. Role of a Candida albicans P1-type ATPase in resistance to copper and silver ion toxicity. J. Bacteriol. 182 (2000) 4899-4905
41. Rogers P.D., and Barker K.S. Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis. Antimicrob. Agents Chemother. 46 (2002) 3412-3417
42. Rogers P.D., and Barker K.S. Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob. Agents Chemother. 47 (2003) 1220-1227
43. Tamai K.T., Gralla E.B., Ellerby L.M., Valentine J.S., and Thiele D.J. Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. USA 90 (1993) 8013-8017
44. van den Hazel H.B., Pichler H., do Valle Matta M.A., Leitner E., Goffeau A., and Daum G. PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs. J. Biol. Chem. 274 (1999) 1934-1941
45. Ververidis P., Davrazou F., Diallinas G., Georgakopoulos D., Kanellis A.K., and Panopoulos N. A novel putative reductase (Cpd1p) and the multidrug exporter Snq2p are involved in resistance to cercosporin and other singlet oxygen-generating photosensitizers in Saccharomyces cerevisiae. Curr. Genet. 39 (2001) 127-136
46. Weissman Z., Shemer R., and Kornitzer D. Deletion of the copper transporter CaCCC2 reveals two distinct pathways for iron acquisition in Candida albicans. Mol. Microbiol. 44 (2002) 1551-1560
47. White T.C., Marr K.A., and Bowden R.A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11 (1998) 382-402
48. White T.C., Holleman S., Dy F., Mirels L.F., and Stevens D.A. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46 (2002) 1704-1713
49. Xu Z., Cao Y.B., Zhang J.D., Cao Y.Y., Gao P.H., Wang D.J., Fu X.P., Ying K., Chen W.S., and Jiang Y.Y. cDNA array analysis of the differential expression change in virulence-related genes during the development of resistance in Candida albicans. Acta Biochim. Biophys. Sin. 37 (2005) 463-472
50. Zhang L. Integrated approaches for discovering novel drugs from microbial natural products. In: Zhang L., and Demain A. (Eds). Natural Products: Drug Discovery and Therapeutics Medicines (2005), Humana Press, Totowa, NJ 33-56
51. Zhang L., An R., Wang J., Sun N., and Kuai J. Isolation of novel bioactive compounds from marine microbes. Curr. Opin. Microbiol. 8 (2005) 276-281